Children with both atopic dermatitis (AD) and alopecia areata (AA) treated with dupilumab showed significant hair regrowth over nearly 68 weeks, according to preliminary results from a small case series. Dr. Emma Guttman-Yassky noted potential for a safe, long-term treatment for children with AA and suggested possible links between atopy and AA. A study of 20 pediatric patients at Mount Sinai found improvements in hair regrowth and alopecia severity scores with dupilumab treatment. Dr. Guttman-Yassky received a grant to further investigate dupilumab for AA treatment in children in a multicenter controlled trial. Additional research is needed to confirm the efficacy and safety of dupilumab in treating AA.
Source link
Future Treatment for Pediatric Alopecia Areata?
